Literature DB >> 22609801

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

Jamie P Nourse1, Pauline Crooks, Colm Keane, Do Nguyen-Van, Sally Mujaj, Nathan Ross, Kimberley Jones, Frank Vari, Erica Han, Ralf Trappe, Susanne Fink, Maher K Gandhi.   

Abstract

Epstein-Barr virus (EBV) is implicated in a range of B-cell malignancies and expresses unique microRNAs (EBV-miRNAs). Due to the requirements for high-quality RNA, studies profiling EBV-miRNA in EBV-positive lymphomas have been restricted to cell-lines or frozen samples. However, the most commonly available archived patient material is paraffin-embedded formalin-fixed (FFPE) tissue. This has impeded the widespread profiling of EBV-miRNA expression in clinical samples. The requirements for accurate EBV-miRNA real-time RT-PCR quantitation in FFPE tissues representing a broad-spectrum of EBV-positive lymphomas were determined systematically, including where the neoplastic cells are sparse relative to the non-malignant infiltrate. The level of cellular EBV-load correlated strongly with the sum of EBV-miRNA expression and the number of EBV-miRNAs detectable. As calibrators for cellular EBV-load, the sum EBV-miRNA was optimal to EBV-genome copy number and EBER2 expression level, with the added advantage of not requiring additional assays. EBV-miRNA was profiled reliably within archival FFPE tissue in 14/23 patients, but not in tissues with low abundance EBV. This method enabled specific and simultaneous detection of numerous EBV-miRNAs in FFPE lymphoma samples that contain EBV at high to medium levels, making it as a useful tool for studies of EBV-miRNA in the majority of diagnostic biopsies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609801     DOI: 10.1016/j.jviromet.2012.05.005

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.

Authors:  Nathan Ross; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2013-08-19

Review 2.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

3.  Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Authors:  Aya Shinozaki-Ushiku; Akiko Kunita; Maya Isogai; Takashi Hibiya; Tetsuo Ushiku; Kenzo Takada; Masashi Fukayama
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.

Authors:  Alexandre S Cristino; Jamie Nourse; Rachael A West; Muhammed Bilal Sabdia; Soi C Law; Jay Gunawardana; Frank Vari; Sally Mujaj; Gayathri Thillaiyampalam; Cameron Snell; Madeline Gough; Colm Keane; Maher K Gandhi
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

5.  EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

Authors:  M K Gandhi; T Hoang; S C Law; S Brosda; K O'Rourke; J W D Tobin; F Vari; V Murigneux; L Fink; J Gunawardana; C Gould; H Oey; K Bednarska; S Delecluse; R U Trappe; L Merida de Long; M B Sabdia; G Bhagat; G Hapgood; E Blyth; L Clancy; J Wight; E Hawkes; L M Rimsza; A Maguire; K Bojarczuk; B Chapuy; C Keane
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

6.  Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.

Authors:  Mohsen Navari; Fabio Fuligni; Maria A Laginestra; Maryam Etebari; Maria R Ambrosio; Maria R Sapienza; Maura Rossi; Giulia De Falco; Davide Gibellini; Claudio Tripodo; Stefano A Pileri; Lorenzo Leoncini; Pier P Piccaluga
Journal:  Front Microbiol       Date:  2014-12-23       Impact factor: 5.640

7.  Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders.

Authors:  Vikas R Dharnidharka; Marianna B Ruzinova; Chun-Cheng Chen; Priyanka Parameswaran; Harry O'Gorman; Charles W Goss; Hongjie Gu; Gregory A Storch; Kristine Wylie
Journal:  Cancer Med       Date:  2019-01-29       Impact factor: 4.452

8.  The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.

Authors:  Maria Raffaella Ambrosio; Mohsen Navari; Lorena Di Lisio; Eduardo Andres Leon; Anna Onnis; Sara Gazaneo; Lucia Mundo; Cristina Ulivieri; Gonzalo Gomez; Stefano Lazzi; Miguel Angel Piris; Lorenzo Leoncini; Giulia De Falco
Journal:  Infect Agent Cancer       Date:  2014-04-14       Impact factor: 2.965

9.  Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.

Authors:  Pier Paolo Piccaluga; Mohsen Navari; Giulia De Falco; Maria Raffaella Ambrosio; Stefano Lazzi; Fabio Fuligni; Cristiana Bellan; Maura Rossi; Maria Rosaria Sapienza; Maria Antonella Laginestra; Maryam Etebari; Emily A Rogena; Lynnette Tumwine; Claudio Tripodo; Davide Gibellini; Jessica Consiglio; Carlo M Croce; Stefano A Pileri; Lorenzo Leoncini
Journal:  Oncotarget       Date:  2016-01-05

10.  Epstein-Barr viral microRNAs target caspase 3.

Authors:  Cecelia Harold; Diana Cox; Kasandra J Riley
Journal:  Virol J       Date:  2016-08-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.